Production (Stage)
CureVac N.V.
CVAC
$5.57
-$0.03-0.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 939.70K | 270.95M | 279.45M | 15.54M | 13.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 939.70K | 270.95M | 279.45M | 15.54M | 13.43M |
| Cost of Revenue | 920.80K | 12.38M | 12.76M | 43.83M | 45.26M |
| Gross Profit | 18.90K | 258.58M | 266.68M | -28.29M | -31.83M |
| SG&A Expenses | 18.37M | 19.78M | 20.40M | 18.40M | 21.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -321.00K | -3.97M | -4.09M | 28.00K | -4.29M |
| Total Operating Expenses | 58.53M | 80.08M | 82.59M | 92.23M | 93.02M |
| Operating Income | -57.59M | 190.87M | 196.86M | -76.69M | -79.59M |
| Income Before Tax | -54.36M | 176.96M | 182.50M | -76.68M | -75.87M |
| Income Tax Expenses | 451.50K | 14.25M | 14.69M | 1.40M | 723.00K |
| Earnings from Continuing Operations | -54.81M | 162.71M | 167.81M | -78.08M | -76.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.81M | 162.71M | 167.81M | -78.08M | -76.59M |
| EBIT | -57.59M | 190.87M | 196.86M | -76.69M | -79.59M |
| EBITDA | -52.77M | 192.36M | 198.39M | -71.17M | -74.31M |
| EPS Basic | -0.24 | 0.72 | 0.75 | -0.35 | -0.34 |
| Normalized Basic EPS | -0.15 | 0.54 | 0.56 | -0.21 | -0.21 |
| EPS Diluted | -0.24 | 0.72 | 0.75 | -0.35 | -0.34 |
| Normalized Diluted EPS | -0.15 | 0.54 | 0.56 | -0.21 | -0.21 |
| Average Basic Shares Outstanding | 225.15M | 224.45M | 224.45M | 224.31M | 224.35M |
| Average Diluted Shares Outstanding | 225.15M | 224.45M | 224.45M | 224.31M | 224.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |